Compare AVTR & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVTR | BIO |
|---|---|---|
| Founded | 1904 | 1952 |
| Country | United States | United States |
| Employees | N/A | 7450 |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 7.1B |
| IPO Year | 2019 | N/A |
| Metric | AVTR | BIO |
|---|---|---|
| Price | $7.72 | $268.44 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 14 | 4 |
| Target Price | $12.89 | ★ $358.50 |
| AVG Volume (30 Days) | ★ 8.9M | 249.7K |
| Earning Date | 04-24-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $6,552,200,000.00 | N/A |
| Revenue This Year | $1.10 | $2.51 |
| Revenue Next Year | $1.90 | $3.17 |
| P/E Ratio | ★ N/A | $9.72 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.58 | $211.43 |
| 52 Week High | $16.79 | $343.12 |
| Indicator | AVTR | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 26.17 | 42.90 |
| Support Level | N/A | $266.71 |
| Resistance Level | $14.29 | $289.61 |
| Average True Range (ATR) | 0.33 | 7.77 |
| MACD | 0.00 | 0.40 |
| Stochastic Oscillator | 9.59 | 31.78 |
Avantor Inc provides products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company operates through two segments: Laboratory Solutions and Bioscience Production. It offers materials & consumables, equipment & instrumentation, and services & specialty procurement. Product groups include Equipment & Instrumentation, Services & Specialty Procurement, Proprietary Materials & Consumables, and Third-Party Materials & Consumables. Materials & consumables include high-purity chemicals and reagents, lab supplies, customized excipients, single-use assemblies, chromatography products, sample preparation kits, and fluid handling solutions. It operates in the Americas, Europe, and AMEA.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.